Would You Buy Your Portfolio plc?

Published in Investing Strategy on 8 December 2009

If your portfolio was quoted on the stock exchange, would you buy it?

If your portfolio was a business, quoted on the stock exchange, would you buy it? Warren Buffett's portfolio, Berkshire Hathaway, is quoted on the stock exchange, but nevertheless he applied his mind to this topic some years ago.

To answer the question, he added the total earnings and dividends generated by each holding, and compared these to the total value of the portfolio. He coined the term 'look-through' to describe this approach to portfolio management, and it can reveal some surprising truths about your investments.

What does it look like?

A simple example would look something like this:

CompanyPrice (p)Quantity (shares)Value (£)EPS (p)Earnings (£)P/E ratio
AstraZeneca (LSE: AZN)2,8432005,686366.07327.8
BAT (LSE: BATS)1,9382003,876136.027214.3
Diageo (LSE: DGE)1,0552502,63868.017015.5
Phytopharm (LSE: PYM)1230,0003,600-2.8-840-4.3
Portfolio  15,800 33447.3

The owner of this portfolio might think he has a fairly conservative core holding, with a little speculative punt in the form of Phytopharm (LSE: PYM) tacked on for some excitement. Would he be surprised to find he that, in aggregate, his portfolio has a price/earnings ratio (P/E) more appropriate to a high-risk strategy?

These situations can sneak up on us, as the relative weightings in a portfolio change over time, and as companies miss or exceed forecasts. Buffett's "look-through" helps us to spot these situations, so we can then decide what, if anything, to do about them.

Practicalities

In practice, this spreadsheet would be extended to include a similar calculation for dividends, and to incorporate any other information you consider relevant. I use results for the last year, and any forecasts for current and future years. From this I can calculate the expected portfolio earnings growth, and portfolio PEG. The spreadsheet also provides a good structure for holding summary qualitative data, and anything I else I regard as relevant, when reviewing my holdings.

Some measures are more suited than others to this approach, so don't forget to use common sense. For example, I wouldn't consider something like dividend cover to be appropriate to a look-through, as the companies are acting independently and a loss or cash-flow problem in one company will not affect the dividend paid out by another.

You'll notice also that it makes no sense to take an average, or weighted average, of the P/Es; instead you need to look at total portfolio earnings and value, and do the calculation on these.

While I still make buy and sell decisions based on the merits of each individual share, I also like to have a feeling for my overall portfolio and how it compares to the market -- I'm aiming to beat the market, after all, otherwise I'd buy a tracker. For that reason, I regard the "look-through" as one of the more useful tools in our investing toolbox.

More from Padraig O'Hannelly:

Share & subscribe

Comments

The opinions expressed here are those of the individual writers and are not representative of The Motley Fool. If you spot any comments that are unsuitable hit the flag to alert our moderators.

guykguard 08 Dec 2009 , 3:02pm

Padraig: far be it from me to seek to appear as too grumpy and old man, but I take issue with the analysis above.
In more than 20 years teaching this kind of stuff to middle aged business executives, I've rarely found anyone who has the foggiest idea what a P/E is. The more numerate ones may be able to calculate it but they rarely have a clue what their calculation signifies!
Your example of Phytopharm means that, at the quoted share price and at the reported annual EPS, it will take minus 4.3 years of annual losses per share of 2.3p to recover the 12p price per share. Sorry, but this is manifest nonsense! I therefore find your conclusions from the data for the portfolio pretty unconvincing.
By virtue of the denominator being, in the examples above, annual earnings per share, the P/E ratio is an indication of the number of years required, at constant EPS, to recover the price paid per share. The reciprocal of the P/E is an indication of the annual earnings yield. I say "indication" because it depends on whether the EPS are historical or forecast. Beware of annual forecasts! In practice, one's pretty lucky if a quarterly forecast turns out to be reliable, as Tesco's results show today! PEG is financial astrology!
If you know all this only too well, I apologize for appearing to teach you to suck eggs. From the way your piece is drafted, it's not obvious that you do, though!

Join the conversation

Please take note - some tags have changed.

Line breaks are converted automatically.

You may use the following tags in your post: [b]bolded text[/b], [i]italicised text[/i]. All other tags will be removed from your post.

If you want to add a link, please ensure you type it as http://www.fool.co.uk as opposed to www.fool.co.uk.

Hello stranger

To add your own comment, please login.

Not yet registered? Register now.